A metabolomics analysis finds that MIEF2 is overexpressed in ovarian cancer cells to cause an elevated concentration of glyceraldehyde 3-phosphate (GA3P), G6P (glucose 6-phosphate), 3PG (3-phosphoglycerate), F6P (fructose 6-phosphate), and lactate in the glycolytic pathway and a reduced concentration of α-ketoglutarate, aconitate, citrate, malate, and fumarate metabolized from the TCA cycle [81]. Here, MIEF2 is linked to ovarian cancer.